The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review

Abstract Background For colorectal liver metastasis (CRLM) patients, hepatic resection is currently the sole cure offering the chance of long-term survival. Tumor shrinkage and planned liver remnant hypertrophy are the two key strategies for conversion of initially unresectable CRLM. First conducted...

Full description

Bibliographic Details
Main Authors: Nan Xiao, Kailin Yu, Shaojun Yu, Jianjun Wu, Jian Wang, Siyang Shan, Shuchun Zheng, Liuhong Wang, Jianwei Wang, Shuyou Peng
Format: Article
Language:English
Published: BMC 2017-08-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12957-017-1212-6
id doaj-6c2623029ec24da7a08827849eba34fb
record_format Article
spelling doaj-6c2623029ec24da7a08827849eba34fb2020-11-25T02:32:02ZengBMCWorld Journal of Surgical Oncology1477-78192017-08-011511510.1186/s12957-017-1212-6The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature reviewNan Xiao0Kailin Yu1Shaojun Yu2Jianjun Wu3Jian Wang4Siyang Shan5Shuchun Zheng6Liuhong Wang7Jianwei Wang8Shuyou Peng9Department of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Radiology and Intervention, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Radiology and Intervention, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of General Surgery, Second Affiliated Hospital of Zhejiang University School of MedicineAbstract Background For colorectal liver metastasis (CRLM) patients, hepatic resection is currently the sole cure offering the chance of long-term survival. Tumor shrinkage and planned liver remnant hypertrophy are the two key strategies for conversion of initially unresectable CRLM. First conducted in 2012, associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) allows rapid liver growth. As a means to induce hypertrophy, portal vein embolization (PVE) has been widely applied before extending hepatectomy. Recently, Peng et al. present a new approach of terminal branches portal vein embolization (TBPVE), offering an efficient way to amplify FLR and making chances for surgery in 2 weeks. Case presentation We reported a 61-year-old woman with synchronous hepatic metastasized carcinoma of the colon sigmoideum underwent TBPVE after 6 cycles of neoadjuvant therapy in order to perform a planned right trisectionectomy. Rapid liver remnant hypertrophy and remarkable tumor shrinkage were achieved, and laparoscopic sigmoidectomy and right trisectionectomy were successfully performed. The postsurgical course was uneventful and 7 months of recurrence-free survival have been witnessed. Conclusions The dual tactics of tumor shrinkage and planned rapid liver remnant hypertrophy will make concerted efforts to further increase the clinical candidacy for curative resection, which are valuable for further investigation.http://link.springer.com/article/10.1186/s12957-017-1212-6Tumor shrinkageLiver remnant hypertrophyUnresectable colorectal liver metastasisPreoperative chemotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Nan Xiao
Kailin Yu
Shaojun Yu
Jianjun Wu
Jian Wang
Siyang Shan
Shuchun Zheng
Liuhong Wang
Jianwei Wang
Shuyou Peng
spellingShingle Nan Xiao
Kailin Yu
Shaojun Yu
Jianjun Wu
Jian Wang
Siyang Shan
Shuchun Zheng
Liuhong Wang
Jianwei Wang
Shuyou Peng
The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
World Journal of Surgical Oncology
Tumor shrinkage
Liver remnant hypertrophy
Unresectable colorectal liver metastasis
Preoperative chemotherapy
author_facet Nan Xiao
Kailin Yu
Shaojun Yu
Jianjun Wu
Jian Wang
Siyang Shan
Shuchun Zheng
Liuhong Wang
Jianwei Wang
Shuyou Peng
author_sort Nan Xiao
title The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
title_short The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
title_full The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
title_fullStr The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
title_full_unstemmed The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
title_sort paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
publisher BMC
series World Journal of Surgical Oncology
issn 1477-7819
publishDate 2017-08-01
description Abstract Background For colorectal liver metastasis (CRLM) patients, hepatic resection is currently the sole cure offering the chance of long-term survival. Tumor shrinkage and planned liver remnant hypertrophy are the two key strategies for conversion of initially unresectable CRLM. First conducted in 2012, associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) allows rapid liver growth. As a means to induce hypertrophy, portal vein embolization (PVE) has been widely applied before extending hepatectomy. Recently, Peng et al. present a new approach of terminal branches portal vein embolization (TBPVE), offering an efficient way to amplify FLR and making chances for surgery in 2 weeks. Case presentation We reported a 61-year-old woman with synchronous hepatic metastasized carcinoma of the colon sigmoideum underwent TBPVE after 6 cycles of neoadjuvant therapy in order to perform a planned right trisectionectomy. Rapid liver remnant hypertrophy and remarkable tumor shrinkage were achieved, and laparoscopic sigmoidectomy and right trisectionectomy were successfully performed. The postsurgical course was uneventful and 7 months of recurrence-free survival have been witnessed. Conclusions The dual tactics of tumor shrinkage and planned rapid liver remnant hypertrophy will make concerted efforts to further increase the clinical candidacy for curative resection, which are valuable for further investigation.
topic Tumor shrinkage
Liver remnant hypertrophy
Unresectable colorectal liver metastasis
Preoperative chemotherapy
url http://link.springer.com/article/10.1186/s12957-017-1212-6
work_keys_str_mv AT nanxiao theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT kailinyu theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT shaojunyu theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT jianjunwu theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT jianwang theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT siyangshan theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT shuchunzheng theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT liuhongwang theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT jianweiwang theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT shuyoupeng theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT nanxiao paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT kailinyu paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT shaojunyu paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT jianjunwu paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT jianwang paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT siyangshan paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT shuchunzheng paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT liuhongwang paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT jianweiwang paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
AT shuyoupeng paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview
_version_ 1724821986426748928